anandron 150 mg, tabletten
cheplapharm arzneimittel gmbh ziegelhof 24 17489 greifswald (duitsland) - nilutamide 150 mg/stuk - tablet - docusaat natrium ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; povidon (e 1201) ; talk (e 553 b), - nilutamide
anandron 150 mg, tabletten
medcor pharmaceuticals b.v. - nilutamide; - tablet - nilutamide
xtandi
astellas pharma europe b.v. - enzalutamide - prostaatnoplasma - endocriene therapie - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
bicalutamide 150 pch, filmomhulde tabletten 150 mg
pharmachemie b.v. swensweg 5 2031 ga haarlem - bicalutamide 150 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; lactose 1-water ; macrogol 4000 ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; polydextrose (e 1200) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; titaandioxide (e 171), - bicalutamide
bicalutamide 50 pch, filmomhulde tabletten 50 mg
pharmachemie b.v. swensweg 5 2031 ga haarlem - bicalutamide 50 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; lactose 1-water ; macrogol 4000 ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; polydextrose (e 1200) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; titaandioxide (e 171), - bicalutamide
bicalutamide accord 50mg filmomhulde tabletten
accord healthcare b.v. winthontlaan 200 3526 kv utrecht - bicalutamide 50 mg/stuk - filmomhulde tablet - hypromellose (e 464) ; lactose 1-water ; macrogol 400 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201) ; titaandioxide (e 171), hypromellose (e 464) ; lactose 1-water ; macrogol 400 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201) ; titaandioxide (e 171), - bicalutamide
bicalutamide bluefish 150mg, filmomhulde tabletten
bluefish pharmaceuticals ab - bicalutamide; - filmomhulde tablet - bicalutamide
bicalutamide bluefish 50 mg, filmomhulde tabletten
bluefish pharmaceuticals ab - bicalutamide; - filmomhulde tablet - bicalutamide
bicalutamide pharmathen 50 mg, filmomhulde tabletten
pharmathen s.a. - bicalutamide; - filmomhulde tablet - bicalutamide
bicalutamide synthon 150 mg, filmomhulde tabletten
synthon b.v. microweg 22 6545 cm nijmegen - bicalutamide - filmomhulde tablet - crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 1-water ; macrogol 4000 ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; povidon k 30 (e 1201) ; titaandioxide (e 171), - bicalutamide